BRIEF-Biocryst Pharmaceuticals - On March 18, Co Withdrew Its Application For Orphan Medicinal Product Designation For Orladeyo

路透社 · Mar 19, 2021 06:13

March 18 (Reuters) - BioCryst Pharmaceuticals Inc :
* BIOCRYST PHARMACEUTICALS - ON MARCH 18, CO WITHDREW ITS APPLICATION FOR ORPHAN MEDICINAL PRODUCT DESIGNATION FOR ORLADEYO™ (BEROTRALSTAT) IN THE EU

Source text for Eikon: [ID: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

BRIEF-Biocryst Pharmaceuticals - On March 18, Co Withdrew Its Application For Orphan Medicinal Product Designation For Orladeyo

Risk Disclaimer